Target intelligence / Profile preview

Dopamine D1-like receptor (DRD1, DRD5)

Target
DRD1, DRD5
Molecular classification
G protein-coupled receptor (GPCR), Receptor, Dopaminergic receptor family, D1-like receptor family (includes D1 and D5 subtypes)
01

Overview

The Dopamine D1-like receptor family (comprising Dopamine receptor D1 and Dopamine receptor D5) represents a group of G protein-coupled receptors that activate adenylyl cyclase via Gs and Golf protein coupling, increasing intracellular cAMP and modulating neural activity. D1-like receptors are primarily located in the striatum, cortex, limbic regions, and other areas of the central nervous system. They regulate motor control, cognition, reward, and emotion and are pivotal in both normal physiology and pathological conditions such as Parkinson’s disease, schizophrenia, and addiction. Pharmacological agents targeting these receptors include agonists, antagonists, and indirect modulators, with ongoing therapeutic research in neuropsychiatric and neurodegenerative disease settings. The D1 receptor especially is the most abundant dopamine receptor in the brain and displays a distinct regulation of gene expression and neuronal function within dopaminergic circuits.

Other names
D1-class dopamine receptorsD1-type receptorsD1-like dopamine receptorsDopaminergic D1 receptorsD5 receptor
02

Mechanism of action

Agonists: stimulate adenylyl cyclase activity via Gs/olf coupling, raising intracellular cAMP, triggering downstream signaling and gene expression changes Antagonists: block dopamine binding, dampening receptor activation and downstream effects Indirect agonists: increase extracellular dopamine, thus stimulating the receptor by dopamine itself

03

Biological functions

Signal transductionRegulation of cAMP levelsControl of gene expressionNeuronal excitabilityModulation of motor controlCognitive function and behaviorReward and motivational processing
04

Disease associations

Parkinson’s diseaseSchizophreniaAddictionCognitive impairmentAttention deficit hyperactivity disorderOther neuropsychiatric and neurodegenerative illnesses
05

Safety considerations

Potential for dyskinesia and motor complicationsPsychosis and impulse control disordersCardiovascular effects with some agonists (e.g., fenoldopam can cause hypotension or tachycardia)Tolerance and abuse risk with drugs that increase dopaminergic tone (e.g., stimulants like cocaine and amphetamine)
06

Interacting drugs

L-DOPA

7 more in the full profile.

07

Biomarkers

Dopamine receptor D1 mRNA levelscAMP production in response to dopaminergic stimulationExpression in specific brain regions on histology

Beyond the preview

Go deeper on Dopamine D1-like receptor (DRD1, DRD5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine D1-like receptor (DRD1, DRD5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call